Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 19 Source: CRO
- €4.4 billion turnover
-
€154.4 million
profit - 10,400 employees
-
31st Dec 18 Source: CRO
- €4.2 billion turnover
-
€255.3 million
profit - 10,400 employees
- 5 more years available »
Ranking
By Turnover
(€4.4 billion)- 29th in Top Companies
- 5th in Health
- 5th in Pharma
By Employees
(10,400)- 22nd in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.4 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- Jul 11 AIB to compensate another 1,100 tracker mortgage holders
- Jul 11 New Powerscourt Springs hotel to open in defiance of virus gloom
- Jul 10 Irish tech firm to facilitate cashless tickets for hurling and football
- Jul 10 Dublin Port expects full-year volumes to be back at 2016 levels
- Jul 10 Business ‘will not survive’ on essential-only travel - task force